Cargando…
Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
The biosynthetic talent of microorganisms has been harnessed for drug discovery for almost a century. Microbial metabolites not only account for the majority of antibiotics available today, but have also led to anticancer, immunosuppressant, and cholesterol-lowering drugs. Yet, inherent challenges o...
Autores principales: | Kunakom, Sylvia, Eustáquio, Alessandra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529544/ https://www.ncbi.nlm.nih.gov/pubmed/31120026 http://dx.doi.org/10.1128/mSystems.00113-19 |
Ejemplares similares
-
Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022) -
50 Years of Women in Cell Biology: Where have we been? Where are we going?
por: Masur, Sandra K., et al.
Publicado: (2021) -
Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020) -
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021) -
The evolution of bacterial genome assemblies - where do we need to go next?
por: Altermann, Eric, et al.
Publicado: (2022)